Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H19BrFNO2 |
| Molecular Weight | 368.241 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CCNCC2=CC=CC=C2F)=C(OC)C=C1Br
InChI
InChIKey=ATMBBMXJNIJRST-UHFFFAOYSA-N
InChI=1S/C17H19BrFNO2/c1-21-16-10-14(18)17(22-2)9-12(16)7-8-20-11-13-5-3-4-6-15(13)19/h3-6,9-10,20H,7-8,11H2,1-2H3
| Molecular Formula | C17H19BrFNO2 |
| Molecular Weight | 368.241 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24397362 |
8.57 null [pKi] | ||
Target ID: CHEMBL324 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24397362 |
7.73 null [pKi] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-N-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography⁻Mass Spectrometry. | 2019-02-25 |
|
| Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. | 2014-03-19 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:08:27 GMT 2025
by
admin
on
Mon Mar 31 23:08:27 GMT 2025
|
| Record UNII |
SSW3KY7SWW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-25B-NBF
Created by
admin on Mon Mar 31 23:08:27 GMT 2025 , Edited by admin on Mon Mar 31 23:08:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
25B-NBF
Created by
admin on Mon Mar 31 23:08:27 GMT 2025 , Edited by admin on Mon Mar 31 23:08:27 GMT 2025
|
PRIMARY | |||
|
1391487-99-2
Created by
admin on Mon Mar 31 23:08:27 GMT 2025 , Edited by admin on Mon Mar 31 23:08:27 GMT 2025
|
PRIMARY | |||
|
DTXSID801337157
Created by
admin on Mon Mar 31 23:08:27 GMT 2025 , Edited by admin on Mon Mar 31 23:08:27 GMT 2025
|
PRIMARY | |||
|
SSW3KY7SWW
Created by
admin on Mon Mar 31 23:08:27 GMT 2025 , Edited by admin on Mon Mar 31 23:08:27 GMT 2025
|
PRIMARY | |||
|
125181239
Created by
admin on Mon Mar 31 23:08:27 GMT 2025 , Edited by admin on Mon Mar 31 23:08:27 GMT 2025
|
PRIMARY | |||
|
25B-NBF
Created by
admin on Mon Mar 31 23:08:27 GMT 2025 , Edited by admin on Mon Mar 31 23:08:27 GMT 2025
|
PRIMARY | 25B-NBF is an N-fluorobenzyl derivative of the phenethylamine hallucinogen 2C-B (Item No. 11734), which acts as a highly potent agonist for the 5-HT2C receptor. 25B-NBF binds human 5-HT2A receptors and rat 5-HT2C receptors with pKi values of 8.57 and 7.73, respectively.1 This product is intended for forensic and research applications. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->PARTIAL AGONIST |
Ki
|